Drug utilisation study in hospitalised chronic kidney disease patients, using World Health Organisation prescribing indicators: an observational study
Not all prescribing indicators evaluated in this study were in full compliance with WHO recommendations. Polypharmacy was found in most participants which might require interventions to avoid DRPs. Further research is needed to evaluate factors associated with prescribing in the CKD population and prescriber perspectives on decision-making in the context of available guidelines and patient factors.
Authors
- Wadia S. Alruqayb (ORCID: https://orcid.org/0000-0002-8600-2909)
- Vibhu Paudyal (ORCID: https://orcid.org/0000-0002-4173-6490)
- Jeff Aston (ORCID: https://orcid.org/0000-0002-7532-198X)
- Asif Sarwar
- Anthony Richard Cox (ORCID: https://orcid.org/0000-0003-2294-3440)
- Malcolm J Price (ORCID: https://orcid.org/0000-0002-7352-3027)
Institutions
- Birmingham City University (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Taif University (SA)
- NIHR Birmingham Biomedical Research Centre (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- Journal of Pharmaceutical Policy and Practice
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1080/20523211.2024.2430436
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00